# An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia

> **NCT05226468** · PHASE1 · UNKNOWN · sponsor: **New Epsilon Innovation Limited** · enrollment: 24 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Relapsed AML
- Refractory AML

## Interventions

- **DRUG:** NEI-01

## Key facts

- **NCT ID:** NCT05226468
- **Lead sponsor:** New Epsilon Innovation Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-25
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05226468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05226468, "An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05226468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*